Selected
Type of publications
Regions
Countries
Diseases
101 results found
2024 ∙ ATAGI
ATAGI statement on the administration of seasonal influenza vaccines in 2024
  • Recommendation
  • Australia
  • Influenza
Download:
2024 ∙ ATAGI
ATAGI statement on Nirsevimab for the prevention of severe disease due to respiratory syncytial virus (RSV) in infants
  • Children
  • Recommendation
  • Australia
  • RSV (Respiratory syncytial virus)
Download:
2023 ∙ Middleton, Bianca F. Danchin, Margie Fathima, Parveen Bines, Julie E. Macartney, Kristine Snelling, Thomas L.
Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021
  • Newborn
  • Children
  • Australia
  • Rotavirus
  • Coverage
  • Efficacy/effectiveness
  • Safety
Rating:
Critically low
2023 ∙ ATAGI
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
  • Recommendation
  • Australia
  • COVID-19
Download:
2023 ∙ ATAGI
ATAGI Update on the COVID-19 Vaccination Program
  • Recommendation
  • Australia
  • COVID-19
Download:
2023 ∙ ATAGI
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
  • Recommendation
  • Australia
  • COVID-19
Download:
2023 ∙ ATAGI
ATAGI advice on seasonal influenza vaccines in 2023
  • Recommendation
  • Australia
  • Influenza
Download:
2023 ∙ ATAGI
ATAGI 2023 booster advice
  • booster dose
  • Recommendation
  • Australia
  • COVID-19
Download:
2023 ∙ ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
  • Pfizer-BioNTech vaccine
  • Recommendation
  • Australia
  • COVID-19
Download:
2022 ∙ ATAGI
ATAGI statement on the intradermal use of Imojev Japanese encephalitis vaccine
  • Recommendation
  • Australia
  • Japanese encephalitis
Download: